Cancer Conversations™: Experts Discuss and Debate Optimal Treatment of Relapsed/Refractory Multiple Myeloma

Watch this on-demand webcast from a live webinar where experts discussed and debated the latest data for the management of patients with relapsed or refractory myeloma.

Shaji K. Kumar, MD
Program Director Suzanne Lentzsch, MD, PhD Saad Z. Usmani, MD, MBA, FACP Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Released: March 31, 2021 Expired: No longer available for credit

Download these slides from a live Webinar for up-to-date data on the optimal treatment options for patients with relapsed or refractory myeloma, including treatment algorithms and data on emerging therapies.

Shaji K. Kumar, MD
Program Director Suzanne Lentzsch, MD, PhD Saad Z. Usmani, MD, MBA, FACP Released: March 15, 2021

Gain key clinical insights fast, with this short slideset from CCO summarizing current and emerging treatment options for patients with relapsed or refractory myeloma.

Shaji K. Kumar, MD
Program Director Suzanne Lentzsch, MD, PhD Saad Z. Usmani, MD, MBA, FACP Released: March 17, 2021

With rapid advances and new drug approvals, it is increasingly challenging to select treatment for advanced myeloma. Read our conversation on current best practices.

Shaji K. Kumar, MD
Program Director Suzanne Lentzsch, MD, PhD Saad Z. Usmani, MD, MBA, FACP Released: March 29, 2021

In this podcast episode, listen to myeloma experts Suzanne Lentzsch, MD, PhD, and Saad Z. Usmani, MD, MBA, FACP, provide their thoughts on optimal treatment for relapsed/refractory multiple myeloma.

Suzanne Lentzsch, MD, PhD Saad Z. Usmani, MD, MBA, FACP Released: June 17, 2021

Download this Podcast Pearls slideset based on the content from a CCO podcast on personalizing therapy for patients with relapsed/refractory multiple myeloma.

Suzanne Lentzsch, MD, PhD Saad Z. Usmani, MD, MBA, FACP Released: June 17, 2021